Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes

Kim E. Kortekaas*, Esther Bastiaannet, Helena C. van Doorn, Peggy J. de Vos van Steenwijk, Patricia C. Ewing-Graham, Carien L. Creutzberg, Kadir Akdeniz, Linda S. Nooij, Sjoerd H. van der Burg, Tjalling Bosse, Mariette I. E. van Poelgeest

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)649-656
Number of pages8
JournalGynecologic Oncology
Volume159
Issue number3
DOIs
Publication statusPublished - Dec 2020

Keywords

  • Vulvar squamous cell carcinoma
  • Human papillomavirus
  • p53
  • p16
  • TP53
  • Molecular classification
  • Prognosis
  • SQUAMOUS-CELL CARCINOMA
  • HUMAN-PAPILLOMAVIRUS HPV
  • RELATIVE SURVIVAL
  • MANAGEMENT
  • DISEASE
  • TRENDS
  • PROGNOSIS
  • SEPARATE
  • LESIONS
  • RISK

Cite this